Scientists of the Institute of Medical Virology in Frankfurt am Main (Germany) conducted a study of the antiviral effect of the drug against SARS-COV-2 virus in a cell model. The drug was tested on human cells infected with SARS-COV-2 Enisamium showed a good effect. This was the reason for starting clinical trials of the drug in Ukraine.
Upon successful completion of the tests, Amizon will be available in all countries where Farmak is present.
Clinical trials will last several months.
“Amizon” as an effective drug for the treatment of influenza and other SARS is already bought by patients in 11 countries – including Belarus, Kazakhstan, Uzbekistan and others.
The book “Bude tobi nauka: ukrainski vcheni, yaki zminiuiut svit” (That’s science for you: Ukrainian scientists changing the world) and the corporate magazine Science inside won the Grand Prix of the competition “The Best Corporate Media of Ukraine 2020”. The competition experts also highly praised other projects of Farmak press service. The corp...
On November 5, 2020 the medicinal product was officially included in the List of Prequalified Medicinal Products by the World Health Organization (WHO) Prequalification of medicinal products is a procedure performed by the WHO to assess the quality, safety and efficacy of medicinal products. The inclusion of the medicinal product in the List of […]
Now eco-businesses can join the Eco-School and support students by funding their projects. The Eco-School continues to extend. An online platform has recently been launched where businesses can select and support students’ eco-projects, and the teams that have been trained and submitted their projects to participate in the competition but have not bee...